Ranbaxy plans Rs.200 crore dosage manufacturing facilityIllustrative image – not actual.

Ranbaxy Laboratories plans to set up a new Rs.200 crore dosage manufacturing facility in a phased manner.

The exact location, capacity and investment in the plant and will be finalised by end-2007.

The facility, that is expected to be approved by the FDA, will supply products globally enabling Ranbaxy to meet worldwide product demand in the next three-five years, when the plant becomes operational.

← All latest storiesBack to top →